Skip to content

Development and validation of a predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis

Development and validation of a predictive model for mild cognitive impairment in elderly patients with rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100701
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis, Cognitive impairment

Interventions

Gold Standard:Diagnostic criteria for rheumatoid arthritis: Complies with the 2010 American College of Rheumatology/European Alliance Against Rheumatism RA diagnostic criteria
Index test:Cognitive function score, anxiety and depression scale, medication use, disease activity score indicators, immunological tests, general laboratory tests

Sponsors

Xi'an Fifth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Part I: Inclusion criteria: (1) 60 years old = 26; (4) reliable medical records; (5) It can be evaluated with psychological scale; (6) Patients voluntarily participated in the trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: Part I: Exclusion criteria: (1) patients with other immune system diseases or connective tissue diseases; (2) Serious medical diseases: such as liver and kidney dysfunction, myocardial infarction, malnutrition, blood system diseases, etc. (3) patients with definite cognitive diseases, such as Alzheimer's disease, cerebral hemorrhage, vascular dementia or sequelae of infarction; (4) history of alcohol or drug abuse. Part II: Exclusion criteria: (1) patients with other immune system diseases or connective tissue diseases; (2) Serious medical diseases: such as liver and kidney dysfunction, myocardial infarction, malnutrition, blood system diseases, etc. (3) patients with definite cognitive diseases, such as Alzheimer's disease, cerebral hemorrhage, vascular dementia or sequelae of infarction; (4) history of alcohol or drug abuse; (5) unable to cooperate with follow-up work.

Design outcomes

Primary

MeasureTime frame
Neurological Function Scale Assessmen;Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Medication situation;Disease Activity Rating Index;Immunological examination;imaging examination;

Countries

China

Contacts

Public ContactYan Jun

Xi'an Fifth Hospital

263329976@qq.com+86 180 6675 3532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026